BNP Paribas Arbitrage, SA
- SEC CIK
- 0001166588
- Latest filing
- Aug 13, 2026
ALPN holding history
Alpine Immune Sciences, Inc. in every 13F filed by BNP Paribas Arbitrage, SA, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALPN overviewAll 13F holders of ALPNFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −77,784−100.0% | Sold out | Holders |
| Q1 2024 | 77,784 | $3.08M | <0.1% | −29,157−27.3% | Reduced | Holders |
| Q4 2023 | 106,941 | $2.04M | <0.1% | +93,423+691.1% | Added | Holders |
| Q3 2023 | 13,518 | $154.8K | <0.1% | +5,029+59.2% | Added | Holders |
| Q2 2023 | 8,489 | $87.3K | <0.1% | −12,029−58.6% | Reduced | Holders |
| Q1 2023 | 20,518 | $158.4K | <0.1% | +5,007+32.3% | Added | Holders |
| Q4 2022 | 15,511 | $114.0K | <0.1% | +8,939+136.0% | Added | Holders |
| Q3 2022 | 6,572 | $47.3K | <0.1% | +3,090+88.7% | Added | Holders |
| Q2 2022 | 3,482 | $29.6K | <0.1% | −295−7.8% | Reduced | Holders |
| Q1 2022 | 3,777 | $33.9K | <0.1% | +531+16.4% | Added | Holders |
| Q4 2021 | 3,246 | $45.0K | <0.1% | +1,130+53.4% | Added | Holders |
| Q3 2021 | 2,116 | $22.6K | <0.1% | +1,668+372.3% | Added | Holders |
| Q2 2021 | 448 | $4.03K | <0.1% | +448 | New | Holders |